Chronic Hepatitis C and Direct Acting Antivirals

Maria Westerhoff, Joseph Ahn

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.

Original languageEnglish (US)
JournalSurgical Pathology Clinics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Chronic Hepatitis C
Hepacivirus
Antiviral Agents
End Stage Liver Disease
Therapeutics
Transplants
Liver
Infection

Keywords

  • Diagnostic criteria
  • Directly acting antivirals
  • Hepatitis C
  • Histology
  • Liver biopsy
  • Transient elastography

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine

Cite this

Chronic Hepatitis C and Direct Acting Antivirals. / Westerhoff, Maria; Ahn, Joseph.

In: Surgical Pathology Clinics, 01.01.2018.

Research output: Contribution to journalArticle

@article{50bec7ed503748a3abfa145d53ef9e4a,
title = "Chronic Hepatitis C and Direct Acting Antivirals",
abstract = "The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50{\%} to more than 90{\%} in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.",
keywords = "Diagnostic criteria, Directly acting antivirals, Hepatitis C, Histology, Liver biopsy, Transient elastography",
author = "Maria Westerhoff and Joseph Ahn",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.path.2018.02.002",
language = "English (US)",
journal = "Surgical Pathology Clinics",
issn = "1875-9181",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Chronic Hepatitis C and Direct Acting Antivirals

AU - Westerhoff, Maria

AU - Ahn, Joseph

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.

AB - The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.

KW - Diagnostic criteria

KW - Directly acting antivirals

KW - Hepatitis C

KW - Histology

KW - Liver biopsy

KW - Transient elastography

UR - http://www.scopus.com/inward/record.url?scp=85044371205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044371205&partnerID=8YFLogxK

U2 - 10.1016/j.path.2018.02.002

DO - 10.1016/j.path.2018.02.002

M3 - Article

JO - Surgical Pathology Clinics

JF - Surgical Pathology Clinics

SN - 1875-9181

ER -